Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent  | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Zhongxing Telecommunications Equipment Corporation and ZTE Kangxun Telecommunications Ltd. | ZTE | telecommunications | export control violation | 2018 | BIS | $1,400,000,000 |
| Sulzer Medica | Zimmer Biomet | medical equipment and supplies | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $1,000,000,000 |
| Wells Fargo | Wells Fargo | financial services | banking violation | 2013 | OCC | $1,991,141,181 |
| Wells Fargo Bank, National Association | Wells Fargo | financial services | False Claims Act and related | 2016 | DOJ_CIVIL | $1,200,000,000 |
| Wells Fargo & Company | Wells Fargo | financial services | mortgage abuses | 2012 | DOJ | $5,342,200,000 |
| Wells Fargo Bank, N.A. | Wells Fargo | financial services | toxic securities abuses | 2018 | DOJ_CIVIL | $2,090,000,000 |
| Wells Fargo | Wells Fargo | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,005,233,716 |
| Wells Fargo | Wells Fargo | financial services | investor protection violation | 2009 | CA-AG | $1,400,000,000 |
| Wells Fargo & Company | Wells Fargo | financial services | fraud | 2020 | DOJ_CIVIL | $3,000,000,000 |
| Wells Fargo Bank | Wells Fargo | financial services | consumer protection violation | 2022 | CFPB | $3,700,000,000 |
| Walmart Stores | Walmart | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $3,100,000,000 |
| Walgreens | Walgreens Boots Alliance | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,700,000,000 |
| Volkswagen AG | Volkswagen | motor vehicles | environmental violation | 2016 | EPA | $14,700,000,000 |
| Volkswagen | Volkswagen | motor vehicles | environmental violation | 2017 | EPA | $4,300,000,000 |
| Volkswagen Group of America | Volkswagen | motor vehicles | consumer protection violation | 2017 | FTC | $4,000,000,000 |
| Volkswagen | Volkswagen | motor vehicles | environmental violation | 2017 | private lawsuit-federal | $1,600,000,000 |
| Volkswagen Group of America | Volkswagen | motor vehicles | environmental violation | 2016 | private lawsuit-federal | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,033,000,000 |
| VOLKSWAGEN OF AMERICA | Volkswagen | motor vehicles | environmental violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,450,000,000 |
| Visa U.S.A. Inc. | Visa | financial services | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $4,100,000,000 |
| Visa USA | Visa | financial services | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $2,025,000,000 |
| Credit Suisse AG | UBS | financial services | tax violations | 2014 | DOJ_TAX | $1,800,000,000 |
| Credit Suisse | UBS | financial services | toxic securities abuses | 2017 | DOJ_CIVIL | $5,280,000,000 |
| UBS Securities LLC and UBS Financial Services, Inc. | UBS | financial services | investor protection violation | 2008 | MULTI-AG | $11,150,000,000 |
| UBS AG | UBS | financial services | toxic securities abuses | 2023 | DOJ_CIVIL | $1,435,000,000 |
| Transocean | Transocean | oilfield services and supplies | environmental violation | 2013 | EPA | $1,000,000,000 |
| Toyota Motor Corporation | Toyota | motor vehicles | motor vehicle safety violation | 2014 | NHTSA | $1,200,000,000 |
| Toyota Motors Sales U.S.A. Inc. | Toyota | motor vehicles | product safety violation | 2017 | private lawsuit-federal | $3,400,000,000 |
| Toyota Motor Corp. | Toyota | motor vehicles | product safety violation | 2013 | private lawsuit-federal | $1,600,000,000 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
| Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
| Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | pharmaceuticals | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
| Stryker Corp. | Stryker | medical equipment and supplies | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $1,425,000,000 |
| Standard & Poor's Financial Services LLC | S&P Global | information technology | toxic securities abuses | 2015 | DOJ | $1,375,000,000 |
| Reckitt Benckiser Group plc | Reckitt Benckiser | household and personal care products | Controlled Substances Act violation | 2019 | USAO | $1,347,000,000 |
| Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
| Pacific Gas & Electric | PG&E Corp. | utilities and power generation | utility safety violation | 2019 | CA-MULTI | $1,000,000,000 |
| Pacific Gas & Electric Co. (PG&E) | PG&E Corp. | utilities and power generation | utility safety violation | 2020 | CA-PUC | $1,937,000,000 |
| Pacific Gas & Electric Co. (PG&E) | PG&E Corp. | utilities and power generation | utility safety violation | 2015 | CA-PUC | $1,600,000,000 |
| Pacific Gas & Electric Co. | PG&E Corp. | utilities and power generation | utility safety violation | 2020 | private lawsuit-federal | $13,500,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| American Home Products | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $3,750,000,000 |
| Ocwen Financial Corporation and Ocwen Loan Servicing | Ocwen Financial | financial services | consumer protection violation | 2013 | CFPB | $2,125,000,000 |
| Anadarko Petroleum Corp. | Occidental Petroleum | oil and gas | environmental violation | 2015 | EPA | $5,150,000,000 |
| Takata Corporation | Ningbo Joyson Electronic | automotive parts | fraud | 2017 | DOJ_CRIMINAL | $1,000,000,000 |
| Navient | Navient | financial services | consumer protection violation | 2022 | MULTI-AG | $1,850,000,000 |
| Royal Bank of Scotland PLC | NatWest Group PLC | financial services | toxic securities abuses | 2017 | FHFA | $5,500,000,000 |
| Royal Bank of Scotland Group plc | NatWest Group PLC | financial services | toxic securities abuses | 2018 | DOJ_CIVIL | $4,900,000,000 |
| Morgan Stanley | Morgan Stanley | financial services | toxic securities abuses | 2016 | DOJ | $2,600,000,000 |
| Morgan Stanley | Morgan Stanley | financial services | toxic securities abuses | 2014 | FHFA | $1,250,000,000 |
| Morgan Stanley | Morgan Stanley | financial services | investor protection violation | 2008 | MULTI-AG | $3,535,000,000 |
| Microsoft Corporation | Microsoft | information technology | price-fixing or anti-competitive practices | 2006 | private lawsuit-state | $1,100,000,000 |
| Facebook, Inc. | Meta Platforms Inc. | information technology | privacy violation | 2019 | FTC | $5,000,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| Merck & Co. | Merck | pharmaceuticals | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
| Daimler AG | Mercedes-Benz Group | motor vehicles | environmental violation | 2020 | EPA | $1,500,000,000 |
| McKesson Corporation | McKesson | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $8,001,000,000 |
| Mastercard International Inc. | MasterCard | financial services | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $2,100,000,000 |
| Mastercard International Inc. | MasterCard | financial services | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $1,025,000,000 |
| Mallinckrodt | Mallinckrodt | pharmaceuticals | Controlled Substances Act violation | 2020 | MULTI-AG | $1,600,000,000 |
| Kroger | Kroger | retailing | off-label or unapproved promotion of medical products | 2023 | MULTI-AG | $1,370,000,000 |
| Knauf Plasterboard Tianjin | Knauf | building materials | product safety violation | 2013 | private lawsuit-federal | $1,000,000,000 |
| El Paso Corporation | Kinder Morgan | pipelines | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $1,450,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | banking violation | 2013 | OCC | $1,958,450,341 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | DOJ | $13,000,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | mortgage abuses | 2012 | DOJ | $5,333,600,000 |
| JPMorgan Chase Bank | JPMorgan Chase | financial services | anti-money-laundering deficiencies | 2014 | USAO | $1,700,000,000 |
| JP Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2008 | MULTI-AG | $3,525,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,121,188,661 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,066,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
| DePuy Orthopaedics, Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| Hyundai Motor America | Hyundai Motor | motor vehicles | product safety violation | 2021 | private lawsuit-federal | $1,300,000,000 |
| HSBC Holdings plc HSBC Bank USA N.A. | HSBC | financial services | anti-money-laundering deficiencies | 2012 | DOJ_CRIMINAL | $1,256,000,000 |
| Halliburton Energy Services Inc. | Halliburton | oilfield services and supplies | environmental violation | 2017 | private lawsuit-federal | $1,028,000,000 |
| Goldman Sachs | Goldman Sachs | financial services | toxic securities abuses | 2016 | DOJ | $5,060,000,000 |
| Goldman Sachs & Co. | Goldman Sachs | financial services | toxic securities abuses | 2014 | FHFA | $3,150,000,000 |
| Goldman Sachs Group, Inc. | Goldman Sachs | financial services | investor protection violation | 2008 | MULTI-AG | $3,355,833,333 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $2,921,088,000 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | SEC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,006,000,000 |
| Glencore International A.G. and Glencore Ltd. | Glencore | financial services | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,185,000,000 |
| Glencore International A.G. | Glencore | financial services | price-fixing or anti-competitive practices | 2022 | CFTC | $1,186,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| General Electric | General Electric | diversified | toxic securities abuses | 2019 | DOJ_CIVIL | $1,500,000,000 |
| Ohio Edison Company | FirstEnergy | utilities and power generation | environmental violation | 2005 | EPA | $1,133,500,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | price-fixing or anti-competitive practices | 2006 | private lawsuit-federal | $1,075,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Cinergy Corporation | Duke Energy | utilities and power generation | environmental violation | 2000 | EPA | $1,430,000,000 |
| Virginia Electric Power Co. | Dominion Energy | utilities and power generation | environmental violation | 2003 | EPA | $1,219,200,000 |
| South Carolina Electric & Gas | Dominion Energy | utilities and power generation | consumer protection violation | 2019 | private lawsuit-state | $2,200,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | toxic securities abuses | 2013 | FHFA | $1,925,000,000 |
| Deutsche Bank | Deutsche Bank | financial services | toxic securities abuses | 2017 | DOJ_CIVIL | $7,200,000,000 |
| Deutsche Bank Securities, Inc. and Deutsche Bank AG | Deutsche Bank | financial services | investor protection violation | 2008 | MULTI-AG | $3,348,333,333 |
| Danske Bank A/S | Danske Bank | financial services | anti-money-laundering deficiencies | 2022 | DOJ_CRIMINAL | $2,000,000,000 |
| CVS | CVS Health | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,000,000,000 |
| Cummins Inc. | Cummins | miscellaneous manufacturing | environmental violation | 2024 | EPA | $2,000,000,000 |
| Citigroup Inc. | Citigroup | financial services | toxic securities abuses | 2014 | DOJ | $7,000,000,000 |
| Citigroup Inc. | Citigroup | financial services | mortgage abuses | 2012 | DOJ | $2,202,000,000 |
